These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21292688)
21. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958 [TBL] [Abstract][Full Text] [Related]
22. Cytogenetic prognostication within medulloblastoma subgroups. Shih DJ; Northcott PA; Remke M; Korshunov A; Ramaswamy V; Kool M; Luu B; Yao Y; Wang X; Dubuc AM; Garzia L; Peacock J; Mack SC; Wu X; Rolider A; Morrissy AS; Cavalli FM; Jones DT; Zitterbart K; Faria CC; Schüller U; Kren L; Kumabe T; Tominaga T; Shin Ra Y; Garami M; Hauser P; Chan JA; Robinson S; Bognár L; Klekner A; Saad AG; Liau LM; Albrecht S; Fontebasso A; Cinalli G; De Antonellis P; Zollo M; Cooper MK; Thompson RC; Bailey S; Lindsey JC; Di Rocco C; Massimi L; Michiels EM; Scherer SW; Phillips JJ; Gupta N; Fan X; Muraszko KM; Vibhakar R; Eberhart CG; Fouladi M; Lach B; Jung S; Wechsler-Reya RJ; Fèvre-Montange M; Jouvet A; Jabado N; Pollack IF; Weiss WA; Lee JY; Cho BK; Kim SK; Wang KC; Leonard JR; Rubin JB; de Torres C; Lavarino C; Mora J; Cho YJ; Tabori U; Olson JM; Gajjar A; Packer RJ; Rutkowski S; Pomeroy SL; French PJ; Kloosterhof NK; Kros JM; Van Meir EG; Clifford SC; Bourdeaut F; Delattre O; Doz FF; Hawkins CE; Malkin D; Grajkowska WA; Perek-Polnik M; Bouffet E; Rutka JT; Pfister SM; Taylor MD J Clin Oncol; 2014 Mar; 32(9):886-96. PubMed ID: 24493713 [TBL] [Abstract][Full Text] [Related]
23. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft. Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498 [TBL] [Abstract][Full Text] [Related]
25. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942 [TBL] [Abstract][Full Text] [Related]
26. Subgroup and subtype-specific outcomes in adult medulloblastoma. Coltin H; Sundaresan L; Smith KS; Skowron P; Massimi L; Eberhart CG; Schreck KC; Gupta N; Weiss WA; Tirapelli D; Carlotti C; Li KKW; Ryzhova M; Golanov A; Zheludkova O; Absalyamova O; Okonechnikov K; Stichel D; von Deimling A; Giannini C; Raskin S; Van Meir EG; Chan JA; Fults D; Chambless LB; Kim SK; Vasiljevic A; Faure-Conter C; Vibhakar R; Jung S; Leary S; Mora J; McLendon RE; Pollack IF; Hauser P; Grajkowska WA; Rubin JB; van Veelen MC; French PJ; Kros JM; Liau LM; Pfister SM; Kool M; Kijima N; Taylor MD; Packer RJ; Northcott PA; Korshunov A; Ramaswamy V Acta Neuropathol; 2021 Nov; 142(5):859-871. PubMed ID: 34409497 [TBL] [Abstract][Full Text] [Related]
27. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Eberhart CG; Kratz JE; Schuster A; Goldthwaite P; Cohen KJ; Perlman EJ; Burger PC Brain Pathol; 2002 Jan; 12(1):36-44. PubMed ID: 11770900 [TBL] [Abstract][Full Text] [Related]
29. Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma. Coco S; Valdora F; Bonassi S; Scaruffi P; Stigliani S; Oberthuer A; Berthold F; Andolfo I; Servidei T; Riccardi R; Basso E; Iolascon A; Tonini GP OMICS; 2011 May; 15(5):273-80. PubMed ID: 21348762 [TBL] [Abstract][Full Text] [Related]
30. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032 [TBL] [Abstract][Full Text] [Related]
31. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation. Nicholson J; Wickramasinghe C; Ross F; Crolla J; Ellison D Mol Pathol; 2000 Dec; 53(6):313-9. PubMed ID: 11193050 [TBL] [Abstract][Full Text] [Related]
32. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma. Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376 [TBL] [Abstract][Full Text] [Related]
33. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645 [TBL] [Abstract][Full Text] [Related]
34. Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization. Nishizaki T; Harada K; Kubota H; Ozaki S; Ito H; Sasaki K Pediatr Neurosurg; 1999 Jul; 31(1):27-32. PubMed ID: 10545819 [TBL] [Abstract][Full Text] [Related]
35. [Detection of chromosomal DNA imbalance in medulloblastoma by comparative genomic hybridization]. Sun YJ; Yu SZ; Sun CY; Wang Q; Jin SM; Wu WX; An TL Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):606-10. PubMed ID: 21092588 [TBL] [Abstract][Full Text] [Related]
36. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930 [TBL] [Abstract][Full Text] [Related]
37. Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling. Nord H; Pfeifer S; Nilsson P; Sandgren J; Popova S; Strömberg B; Alafuzoff I; Nistér M; Díaz de Ståhl T J Neurooncol; 2012 Mar; 107(1):37-49. PubMed ID: 21979893 [TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of chromosome 17p deletions in human medulloblastomas. Batra SK; McLendon RE; Koo JS; Castelino-Prabhu S; Fuchs HE; Krischer JP; Friedman HS; Bigner DD; Bigner SH J Neurooncol; 1995; 24(1):39-45. PubMed ID: 8523074 [TBL] [Abstract][Full Text] [Related]
39. Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma. Vriend J; Liu XQ Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062749 [TBL] [Abstract][Full Text] [Related]
40. Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Clifford SC; Lusher ME; Lindsey JC; Langdon JA; Gilbertson RJ; Straughton D; Ellison DW Cell Cycle; 2006 Nov; 5(22):2666-70. PubMed ID: 17172831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]